Redfund Capital Corp. (CSE:LOAN, OTC:PNNRF, Frankfurt:O3X4) (Redfund Capital or the “Company”) is pleased to announce the Company has signed the definitive agreement for an equity stake in the Sunshine State Tea Company (“SSTC”), based in Florida, USA.

Sunshine State Tea’s main product line is tasty infused CBD tea that has been tested to reveal zero percent THC. There are 8 varieties of tea; 4 caffeinated blends and 4 herbal decaffeinated ones. Each 8 tea bundle box has a diverse selection of flavors with 10mg CBD in each tea bag. Sunshine State production is manufactured in Washington State. The tea bags are certified and tested at a third party approved lab facility to authenticate and analyze the milligrams of CBD in the individual bags.


These are the terms of the definitive option agreement signed on February 6, 2020 between Redfund Capital and the Sunshine State Tea Company which supersedes the letter of interest signed in November 2019 between the parties. The Company has agreed to purchase 18% of SSTC with consideration in common shares and has agreed to the valuation of Sunshine State Tea being CDN $1,500,000. The share issuance allotment will reflect current market price at the time of issuance and have a 4 month hold period. The Company will allocate CDN $500,000 in a promissory note towards the project within the first 3 years. Terms of the Note will be disclosed after the signing.

This transaction, which is expected to close shortly, is a non arms-length transaction in that Meris Kott, CEO of Redfund, is an insider of the other party. Redfund is relying on certain valuation and minority approval exemptions from MI 61 -101. Independent members of the board of Redfund have reviewed and approved the transaction.

A Few of Our Portfolio Company Updates from their Management:

Biominerales Pharma Corp. is reporting they are continuing to increase their revenues Stateside. At their Colorado subsidiary, they are processing CBD distillate free from THC from their organic hemp crop and manufacturing a branded product line under the Hempire Farms logo. www.hempirefarms.com

RxMM Health Capital Inc. is working with associated company, Clerisy Corporation, of New York, to launch their Alzheimer Defense Product. Its ALZ Defense Gelcaps have already been scientifically tested for Alzheimer Onset Prevention Support.

Wahupta Ventures Inc. is working hard to increase their revenues by building strategic alliances in the hemp-cbd marketplace and extraction sector. They are navigating the stringent due diligence process to the public markets and evaluating the timing for their listing to an approved public exchange.

Mary’s Wellness Ltd. is working with Canadian licensed partners and regulators on their product approval for new lines of their infused beverages with the intent to bring to the Canadian marketplace, new and dynamic forms of their branded classic tea products for consumers. Virginia Vidal, CEO will be speaking on a panel at the O’Cannabiz conference in Toronto on Friday April 24, 2020.

“Redfund Capital has established the first tier of its investment client portfolio during its first fiscal year. The Company’s focus in 2020 will be in developing additional revenue streams with advisory services and joint venture partnerships. Additionally, we are pursuing meaningful acquisitions as part of a new aggressive M&A strategy. Our current loans are in good standing and we are looking forward to expanding our portfolio. This new relationship with Sunshine State Tea was designed to help position Redfund as a player in a well-defined, high-growth niche within the rapidly expanding non THC CBD and hemp sector,” said Meris Kott, CEO.

About Redfund Capital Corp.

Redfund provides debt and equity funding plus advisory services to mid-to-late stages of a target company’s development, or in technologies that are developed and validated by revenues. The present focus of the merchant bank is on medical cannabis, hemp and CBD-related, healthcarerelated target companies.

For further information please visit www.redfundcapital.com

For more information on Redfund Capital contact

Meris Kott CEO 604.484.8989

0r info@redfundcapital.com

Further information about the Company is available on www.SEDAR.com under the Company’s profile.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. Certain statements contained in this release may constitute “forward–looking statements” or “forward-looking information” (collectively “forward-looking information”) as those terms are used in the Private Securities Litigation Reform Act of 1995 and similar Canadian laws. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated”, “anticipates” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company’s current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to the business of the Company, the Property, financing and certain corporate changes. The forward-looking information contained in this release is made as of the date hereof and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein.

Click here to connect with Redfund Capital Corporation (CSE:LOAN) for an Investor Presentation.

Source

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

A middling Canadian cannabis producer announced an executive turnover plan this week after receiving a critical investor letter in September.

Meanwhile, a Canadian exchange-traded fund (ETF) company released lists of new additions to both of its cannabis funds as part of its quarterly rebalancing.

Keep reading... Show less
  • The Cannabis Derivatives are derived from Avicanna’s cultivation and extraction infrastructure in Santa Marta, Colombia designed to supply partner companies and the manufacture of Avicanna’s own finished products.

Avicanna Inc. (” Avicanna ” or the ” Company “) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products, is pleased to announce that, through its majority owned Colombian subsidiary, Santa Marta Golden Hemp S.A.S. (“ SMGH ”), it has completed a commercial exports of CBD Isolate and CBD full spectrum psychoactive cannabis resin (the “ Cannabis Derivatives ”) to a leading Chilean homeopathic and naturopathic pharmaceutical company.

The Cannabis Derivatives, branded as Aureus™, are cultivated, extracted, and manufactured by SMGH. In addition, for Avicanna’s global input needs, SMGH also supplies other pharmaceutical and cosmetics companies with cannabinoids including CBD, THC, and rare cannabinoids such as CBG in addition to supplying global cultivation companies with standardized and feminized seeds. This new export to Chile is a recurring order and part of on-going relationship with an established homeopathic Chilean company.

Keep reading... Show less

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED, NASDAQ:CGC) will release its financial results for the second quarter fiscal year 2022 ended September 30, 2021 before financial markets open on November 5, 2021 .

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or “the Company”), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, announced today the opening of a new Sunnyside dispensary in Wyomissing, Pennsylvania. Wyomissing will be Cresco Labs’ fifth dispensary in Pennsylvania and 38 th nationwide.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211021006075/en/

Keep reading... Show less

The world of cannabis consumption is set to change radically, thanks in large part to the advancement of state-of-the-art research on the plant itself.

Medical cannabis products have already allowed many new users to discover the plant’s potential, but decisive research will help build a foundation for more sophisticated medical offerings.

Keep reading... Show less